Polymorphic hydroxylation of debrisoquine in Nigerians [proceedings].
作者信息
Bababunmi A, Idle J R, Mahgoub A, Mbanefo C, Smith R L
出版信息
Br J Clin Pharmacol. 1980 Jan;9(1):112P-113P. doi: 10.1111/j.1365-2125.1980.tb04814.x.
Abstract
摘要
相似文献
1
Polymorphic hydroxylation of debrisoquine in Nigerians [proceedings].尼日利亚人中美托洛尔的多态性羟基化反应[会议论文集]
Br J Clin Pharmacol. 1980 Jan;9(1):112P-113P. doi: 10.1111/j.1365-2125.1980.tb04814.x.
2
Stereoselective 4-hydroxylation of debrisoquine in Nigerians.
Biochem Pharmacol. 1988 Jan 1;37(1):97-8. doi: 10.1016/0006-2952(88)90759-9.
3
Polymorphic hydroxylation of debrisoquine in Ghanaians [proceedings].加纳人去甲丙咪嗪的多态性羟基化反应[会议论文集]
Br J Pharmacol. 1979 Jul;66(3):431P.
4
Non-correlation between debrisoquine and metoprolol polymorphisms in the Venda.
Hum Toxicol. 1989 Sep;8(5):365-8. doi: 10.1177/096032718900800506.
5
Polymorphism of the 4-hydroxylation of debrisoquine in the San Bushmen of southern Africa.
Hum Toxicol. 1988 May;7(3):273-6. doi: 10.1177/096032718800700308.
6
4-Hydroxylation of debrisoquine in psoriasis [proceedings].
Br J Clin Pharmacol. 1980 Jan;9(1):113P-114P. doi: 10.1111/j.1365-2125.1980.tb04815.x.
7
Stereoselective metabolism of metoprolol in Caucasians and Nigerians--relationship to debrisoquine oxidation phenotype.美托洛尔在白种人和尼日利亚人中的立体选择性代谢——与异喹胍氧化表型的关系。
Br J Clin Pharmacol. 1989 May;27(5):613-6. doi: 10.1111/j.1365-2125.1989.tb03424.x.
8
Polymorphic hydroxylation of debrisoquine.
Lancet. 1977 Oct 1;2(8040):718. doi: 10.1016/s0140-6736(77)90527-x.
9
Metoprolol and debrisoquin metabolism in Nigerians: lack of evidence for polymorphic oxidation.尼日利亚人美托洛尔和异喹胍的代谢：缺乏多态性氧化的证据。
Clin Pharmacol Ther. 1986 Oct;40(4):387-94. doi: 10.1038/clpt.1986.195.
10
Relationship of N-demethylation of amiflamine and its metabolite to debrisoquine hydroxylation polymorphism.
Clin Pharmacol Ther. 1984 Oct;36(4):515-9. doi: 10.1038/clpt.1984.212.
Zotero 插件